Drug formulations & biologicals keep India's pharma exports healthy in Q1
Cite this
Citations are auto-generated; verify before publishing. The analysis classification is PolicyDhara's, not the source's.
Research or analytical publication — an evidence-based assessment informing policy design and evaluation. Shapes the intellectual framework within which policy debates occur.
Summary
India’s pharma exports grew 6.8% in Q1 FY27, supported by drug formulations and biologicals, while strong growth in vaccines and bulk drugs and expanding demand across global markets strengthened the sector’s export performance.